Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients (Q48628621)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 July 2014

Language	Label	Description	Also known as
English	Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients	scientific article published on 31 July 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

Alzheimer's disease

0 references

Michael Schöll

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

Stephen F Carter

object named as

Stephen F Carter

2

0 references

Agneta Nordberg

4

object named as

Agneta Nordberg

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

author name string

I L Han Choo

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

publication date

31 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

number of pages

7

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

41

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

11

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

2120-2126

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Astrocytes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

In vivo imaging of astrocytosis in Alzheimer's disease: an ¹¹C-L-deuteriodeprenyl and PIB PET study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Revising the definition of Alzheimer's disease: a new lexicon.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

The importance of impaired physical health and age in normal cognitive aging.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Beta-amyloid burden is not associated with rates of brain atrophy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

A new role for astrocytes: beta-amyloid homeostasis and degradation

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

The use of PET in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2859-7

21 January 2018

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/25077930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/25077930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between atrophy and beta-amyloid deposition in Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25077930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25077930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

1 reference

https://pubmed.ncbi.nlm.nih.gov/25077930

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-014-2859-7

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25077930

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48628621&oldid=2209654358"